Alvesco approved for asthma Sepracor has launched Alvesco (ciclesonide) inhalation aerosol for the prophylactic and maintenance treatment of asthma in patients ≥12 years of age. Sepracor has launched ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results